HRT Financial’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-42,716
Closed -$3.38M – 4917
2025
Q4
$3.38M Buy
42,716
+39,719
+1,325% +$3.04M 0.01% 982
2025
Q3
$218K Buy
+2,997
New +$220K ﹤0.01% 2368
2025
Q2
– Sell
-9,842
Closed -$748K – 3689
2025
Q1
$748K Sell
9,842
-48,703
-83% -$3.63M ﹤0.01% 1268
2024
Q4
$3.87M Sell
58,545
-10,876
-16% -$761K 0.02% 477
2024
Q3
$4.84M Buy
+69,421
New +$4.18M 0.02% 474

Other funds holding SOLV

HRT Financial's SOLV Position: Q1 2026 in Review

HRT Financial sold out of Solventum (SOLV) in Q1 2026, closing a stake of 42,716 shares — an estimated $3.38M sold.

HRT Financial first reported a position in SOLV in Q3 2024 and held it in 5 quarters. The position peaked at $4.84M in Q3 2024. 885 funds tracked by Wall St. Rank hold SOLV as of Q1 2026.

  • HRT Financial reported no remaining Solventum position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 42,716 Solventum shares in Q1 2026, an estimated $3.38M.
  • HRT Financial first reported a position in Solventum in Q3 2024 and held it in 5 quarters.
  • HRT Financial's Solventum position peaked at $4.84M in Q3 2024.
  • 885 funds tracked by Wall St. Rank held Solventum as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.